Zoom, Roku, Novavax and more

A trader working after the Nasdaq opening bell ceremony on April 18, 2019 in New York City.

Kena Betancur | Getty Images

Take a look at the companies that make headlines after Monday:

Zoom Video – Shares of the video communications company rose 8.5% due to better-than-expected fiscal results in the fourth quarter. Zoom earned $ 1.22 per share on $ 882 million in revenue. Analysts at Refinitiv expected a profit of 79 cents per share on revenue of $ 812 million. The revenue figure represents a 369% increase on a year-on-year basis. Zoom also expects revenue to increase by 175% in the first fiscal quarter and by 42% for the full financial year.

Roku – Roku’s share jumped 2.8% on the news that the company will acquire Nielsen’s video advertising business. “By combining Nielsen’s AVA technology with Roku’s innovative advertising technology and scale, we can deliver the benefits of TV streaming advertising to traditional TV,” said Louqman Parampath, Roku’s vice president of product management, in a statement.

Novavax – The vaccine developer’s share slipped by 4.2% after weaker-than-expected fourth-quarter results. Novavax lost $ 2.70 per share on revenue of $ 279.7 million. Analysts surveyed by Refinitv expected a loss of $ 1.49 per share on revenue of $ 304.9 million. CEO Stanley Erck told CNBC that the company is already expecting government approval for its Covid-19 vaccine in May.

Inovio Pharmaceuticals – Inovio shares slipped more than 6% after the company announced its latest quarterly figures. The company lost 14 cents a share, while analysts surveyed by FactSet expected a loss of 22 cents a share. In addition, Inovio has released Phase 3 trial results for a drug aimed at treating HPV.

.Source